Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
K. Rachael Parks(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Leonidas Stamatatos(University of Washington)
Cited by 55
Related Papers
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
|The Journal of Experimental Medicine|2013|324
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
|PLoS Pathogens|2013|191
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual
|bioRxiv (Cold Spring Harbor Laboratory)|2020|78
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial
|Science Translational Medicine|2025|40
Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies
|The Journal of Experimental Medicine|2024|28